7Baggers
 Akebia Therapeutics Amends License Agreement with MEDICE  TipRanks Mon, 17 Nov 2025 13:27:13 GMT
 Akebia Therapeutics Shares Extend Decline Amid Analyst Downgrades  AD HOC NEWS Mon, 17 Nov 2025 10:08:05 GMT
 akebia stock target lowered as fda misalignment impacts clinical trial  StocksToTrade Sat, 15 Nov 2025 02:54:00 GMT
 Akebia Therapeutics Faces Challenges with VALOR Clinical Trial  StocksToTrade Sat, 15 Nov 2025 02:21:00 GMT
 akebia therapeutics faces challenges with valor clinical trial  StocksToTrade Fri, 14 Nov 2025 23:10:52 GMT
 Akebia Therapeutics Faces Scrutiny After FDA Disagreement  timothysykes.com Fri, 14 Nov 2025 21:10:00 GMT
 q2 earnings forecast for akba issued by hc wainwright  MarketBeat Fri, 14 Nov 2025 17:36:10 GMT
 Implied Volatility Surging for Akebia Therapeutics Stock Options  Yahoo Finance Thu, 13 Nov 2025 16:01:00 GMT
 Analysts Offer Predictions for AKBA Q1 Earnings  MarketBeat Thu, 13 Nov 2025 14:28:29 GMT
 Akebia Therapeutics (AKBA) Receives a Buy from BTIG  The Globe and Mail Wed, 12 Nov 2025 22:04:09 GMT
 Akebia Therapeutics’ Earnings Call: Growth Amid Challenges  TipRanks Wed, 12 Nov 2025 00:12:53 GMT
 akebia reports q3 eps 0c vs (10c) last year  TipRanks Tue, 11 Nov 2025 05:59:09 GMT
 Akebia Therapeutics Reports Strong Q3 2025 Growth  TipRanks Tue, 11 Nov 2025 04:04:55 GMT
 akebia at guggenheim conference: strategic moves in anemia treatment  Investing.com Mon, 10 Nov 2025 22:22:11 GMT
 akebia therapeutics q3 2025 earnings call transcript  MarketBeat Mon, 10 Nov 2025 16:01:25 GMT
 akebia (akba) surpasses q3 earnings and revenue expectations  GuruFocus Mon, 10 Nov 2025 14:12:47 GMT
 Akebia Therapeutics Turns A Profit And Impresses Wall Street  Finimize Mon, 10 Nov 2025 13:13:53 GMT
 Akebia Therapeutics, Inc. (AKBA) Q3 FY2025 earnings call transcript  Yahoo Finance Mon, 10 Nov 2025 13:00:00 GMT
 Akebia Therapeutics, Inc. SEC 10-Q Report  TradingView Mon, 10 Nov 2025 12:43:00 GMT
 akebia (akba) reports strong q3 revenue, projects growth for vaf  GuruFocus Mon, 10 Nov 2025 12:41:50 GMT
 Akebia Therapeutics Q3 revenue rises  MarketScreener Mon, 10 Nov 2025 12:29:45 GMT
 akebia therapeutics (akba) expected to announce earnings on monday  Defense World Sat, 08 Nov 2025 06:24:15 GMT
 akebia therapeutics shares rally on promising drug data  AD HOC NEWS Fri, 07 Nov 2025 10:19:04 GMT
 vafseo® (vadadustat) dialysis dependent patient post hoc  GlobeNewswire Thu, 06 Nov 2025 23:30:00 GMT
 Akebia Therapeutics to Present at Upcoming Investor Conferences  Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
 Akebia Therapeutics Securities Lawsuit Investigation  Claim Depot Mon, 03 Nov 2025 16:15:59 GMT
 Q3 EPS Estimate for Akebia Therapeutics Increased by Analyst  MarketBeat Mon, 03 Nov 2025 08:00:00 GMT

Akebia Therapeutics, Inc
(NASDAQ:AKBA) 

AKBA stock logo

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the tre...

Full Time Employees: 358
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends